Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PLX51107 |
| Trade Name | |
| Synonyms | PLX-51107|PLX 51107 |
| Drug Descriptions |
PLX51107 is a small molecule BET inhibitor, which binds to BET bromodomains in BRD2, BRD3, BRD4, and BRDT, potentially resulting in decreased tumor cell proliferation (PMID: 29386193, PMID: 31063649, PMID: 32717030). |
| DrugClasses | BET Inhibitor (Pan) 33 |
| CAS Registry Number | 1627929-55-8 |
| NCIT ID | C125739 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Azacitidine + PLX51107 | Azacitidine PLX51107 | 0 | 1 |
| Dinaciclib + PLX51107 | Dinaciclib PLX51107 | 0 | 0 |
| PLX51107 | PLX51107 | 0 | 1 |